Beranda › Kanker (semua jenis) › Virginia › Arlington
Uji klinis Kanker (semua jenis) di Arlington, VA
48 studi untuk Kanker (semua jenis) mencari peserta di lokasi sekitar Arlington (dalam radius sekitar 30 mil). Buka studi untuk melihat kriteria peserta dan cara menghubungi tim studi.
Teks studi resmi (Bahasa Inggris)
Merekrut peserta untuk studi di sini? Tampilkan di bagian atas halaman ini — $99 selama 30 hari →
Phase 1/2 Study of BHB810 in Advanced Gastric and GEJ Adenocarcinoma
Menerima pesertaFase 1/2
- NEXT Virginia, Fairfax · 11 mi jauhnya
A Study to Assess Change in Disease Activity and Adverse Events in Adult Participants With Gynecologic Cancers Receiving Intravenous Infusion of IMGN151 as Monotherapy or in Combination With Other Therapies
Menerima pesertaFase 2
- Next Virginia /ID# 279684, Fairfax · 11 mi jauhnya
A Clinical Study of Calderasib (MK-1084) in People With Advanced Solid Tumors (MK-1084-014)
Menerima pesertaFase 2
- Virginia Cancer Specialists ( Site 1102), Fairfax · 11 mi jauhnya
A Study of ASP3082 in Adults With Advanced Solid Tumors
Menerima pesertaFase 1
- NEXT Oncology - Virginia Cancer Specialists, Fairfax · 11 mi jauhnya
REC-7735 in Participants With Solid Tumors
Menerima pesertaFase 1/2
- NEXT Virginia, Fairfax · 11 mi jauhnya
Registry Study for Radiation Therapy Outcomes
Menerima pesertaStudi observasional
- Inova Schar Cancer Institute, Fairfax · 11 mi jauhnya
A Study of PHN-012 in Patients With Advanced Solid Tumors
Menerima pesertaFase 1
- PHN-012-001 Site, Fairfax · 11 mi jauhnya
Beginning Radiation Immediately With GammaTile at GBM Excision Versus Standard of Care
Menerima pesertaFase 3
- Inova Schar Cancer Institute, Fairfax · 11 mi jauhnya
A Study of NEOK001, a B7-H3 and ROR1 Targeting Bispecific ADC in Participants With Select Solid Tumors
Menerima pesertaFase 1
- NEXT Oncology, Fairfax · 11 mi jauhnya
A Study of Zolbetuximab Together With Pembrolizumab and Chemotherapy in Adults With Gastric Cancer
Menerima pesertaFase 3
- Inova Schar Cancer Institute Clinical Trials, Fairfax · 11 mi jauhnya
A Study to Evaluate Adverse Events and Change in Disease Activity of Intravenous ABBV-706 Versus Standard of Care in Adult Participants With Relapsed/Refractory Small Cell Lung Cancer
Menerima pesertaFase 3
- Virginia Cancer Specialists - Fairfax /ID# 280710, Fairfax · 11 mi jauhnya
Study of Elironrasib and Daraxonrasib as Monotherapies and Combination Therapy in Participants With Advanced KRAS G12C Mutant Solid Tumors
Menerima pesertaFase 1/2
- NEXT Oncology Virginia, Fairfax · 11 mi jauhnya
TAPUR: Testing the Use of Food and Drug Administration (FDA) Approved Drugs That Target a Specific Abnormality in a Tumor Gene in People With Advanced Stage Cancer
Menerima pesertaFase 2
- Inova Schar Cancer Institute, Fairfax · 11 mi jauhnya
A Clinical Study of MK-4716 in People With Certain Solid Tumors (MK-4716-001)
Menerima pesertaFase 1
- NEXT Virginia ( Site 0054), Fairfax · 11 mi jauhnya
Safety, Pharmacokinetics, and Preliminary Efficacy of VIR-5500 (AMX-500) in Prostate Cancer
Menerima pesertaFase 1
- Investigational Site number: 404, Fairfax · 11 mi jauhnya
A Phase 1/1b Study of IAM1363 in HER2 Cancers
Menerima pesertaFase 1
- NEXT Oncology - Virginia Cancer Specialists, Fairfax · 11 mi jauhnya
A Study to Evaluate Safety, Tolerability and Preliminary Activity of AGX101 in Participants With Advanced Solid Tumors
Menerima pesertaFase 1
- NEXT Oncology, Fairfax · 11 mi jauhnya
A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer
Menerima pesertaFase 3
- USO - Virginia Cancer Specialists, Fairfax · 11 mi jauhnya
A Study of ERAS-0015 in Patients With Advanced or Metastatic Solid Tumors
Menerima pesertaFase 1
- NEXT Virginia, Fairfax · 11 mi jauhnya
A Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Anti-tumor Activity of CBI-1214 T Cell Engager in Participants With Advanced or Metastatic MSS/MSI-L Colorectal Cancer
Menerima pesertaFase 1
- NEXT Oncology, Fairfax · 11 mi jauhnya
Project: Every Child for Younger Patients With Cancer
Menerima pesertaStudi observasional
- Inova Fairfax Hospital, Falls Church · 4 mi jauhnya
A Clinical Trial to Assess COM503 in Participants With Advanced Solid Malignancies
Menerima pesertaFase 1
- NEXT Oncology Virginia, Fairfax · 11 mi jauhnya
A Study of ASP1002 in Adults for Treatment of Solid Tumors
Menerima pesertaFase 1
- NEXT Oncology Virginia, Fairfax · 11 mi jauhnya
Relacorilant in Combination With Different Treatment Regimens in Patients With Gynecological Cancers
Menerima pesertaFase 2
- 522, Fairfax · 11 mi jauhnya
A Study of CHS-114 (Tagmokitug) in Combination With Toripalimab and/or Other Treatments in Participants With Advanced Solid Tumors
Menerima pesertaFase 1
- Virginia Cancer Specialists, Fairfax · 11 mi jauhnya
A Study to Assess Adverse Events of Intravenously (IV) Infused Etentamig (ABBV-383) in Adult Participants With Relapsed or Refractory Multiple Myeloma
Menerima pesertaFase 1
- Virginia Cancer Specialists - Fairfax /ID# 268559, Fairfax · 11 mi jauhnya
A Study to Assess Adverse Events and Change in Disease Activity in Adult Participants Receiving Intravenously Infused Telisotuzumab Adizutecan Alone or With Standard of Care in Participants With Post Adjuvant Circulating Tumor DNA Positive Colorectal Cancer and No Radiographic Evidence of Disease
Menerima pesertaFase 2
- Inova Schar Cancer Institute - Fairfax - Innovation Park Drive /ID# 274586, Fairfax · 11 mi jauhnya
- Virginia Cancer Specialists - Fairfax /ID# 274339, Fairfax · 11 mi jauhnya
First-in-Human Study of Tersolisib (STX-478) as Monotherapy and in Combination With Other Antineoplastic Agents in Participants With Advanced Solid Tumors
Menerima pesertaFase 1/2
- USO-Virginia Cancer Specialists, PC, Fairfax · 11 mi jauhnya
Burn Pit Exposure in Veterans: A Cancer Screening Pilot Study at the Inova Saville Cancer Screening & Prevention Center
Menerima pesertaSukarelawan sehat diterima
- Inova Schar Cancer Institute, Fairfax · 11 mi jauhnya
Study of RAS(ON) Inhibitors in Patients With Advanced RAS-mutated NSCLC
Menerima pesertaFase 1/2
- NEXT Oncology Virginia, Fairfax · 11 mi jauhnya
Phase 1/2 Study of ETX-636 in Participants With Advanced Solid Tumors
Menerima pesertaFase 1/2
- NEXT, Fairfax · 11 mi jauhnya
Occupational Cancer Screening in Firefighters: A Pilot Study Within the Inova Health System
Menerima peserta
- Inova Schar Cancer - Saville Cancer Screening and Prevention Center, Fairfax · 11 mi jauhnya
A Study to Learn About Study Medicine ALTA3263 in Adults With Advanced Solid Tumors With KRAS Mutations
Menerima pesertaFase 1
- Research Site, Fairfax · 11 mi jauhnya
A Study to Assess Adverse Events, Change in Disease Activity of Intravenous Telisotuzumab Adizutecan in Combination With Osimertinib as First-Line Treatment in Adult Participants With Locally Advanced Unresectable or Metastatic EGFR-Mutated Non-Squamous Non-Small Cell Lung Cancer
Menerima pesertaFase 2/3
- Virginia Cancer Specialists - Fairfax /ID# 275071, Fairfax · 11 mi jauhnya
A Study to Find a Suitable Dose of ASP5834 in Adults With Solid Tumors
Menerima pesertaFase 1
- NEXT Oncology Virginia, Fairfax · 11 mi jauhnya
A First-in-Human (FIH) Study to Evaluate the Safety and Tolerability of VVD-130037 in Participants With Advanced Solid Tumors
Menerima pesertaFase 1
- NEXT Virginia, Fairfax · 11 mi jauhnya
A Study of TSN1611 Treating Patients With Advanced Solid Tumors Harboring KRAS G12D Mutation
Menerima pesertaFase 1/2
- NEXT Virginia, Fairfax · 11 mi jauhnya
A Study to Investigate the Safety and Efficacy of NST-628 Oral Tablets in Subjects With Solid Tumors
Menerima pesertaFase 1
- NEXT Oncology - Virginia, Fairfax · 11 mi jauhnya
Study Evaluating the Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of TGW101 in Participants With Advanced Solid Tumors
Menerima pesertaFase 1
- NEXT Virginia, Fairfax · 11 mi jauhnya
Phase I Study of SYS6043 in Patients With Advanced/Metastatic Solid Tumors
Menerima pesertaFase 1
- NEXT Oncology Virginia, Fairfax · 11 mi jauhnya
A Phase 1 Study of CPO301 in Adult Patients With Advanced or Metastatic Solid Tumors
Menerima pesertaFase 1
- NEXT Virginia, Fairfax · 11 mi jauhnya
Safety, PK, and Preliminary Efficacy of MBRC-101 in Advanced Refractory Solid Tumors
Menerima pesertaFase 1/2
- NEXT Oncology, Fairfax · 11 mi jauhnya
A Phase 1 Study of JMT108 in Participants With Advanced Solid Tumors
Menerima pesertaFase 1
- NEXT Virginia, Fairfax · 11 mi jauhnya
Evaluation of RBS2418 in Subjects With Advanced, Metastatic Solid Tumors
Menerima pesertaFase 1
- NEXT Virigina, Fairfax · 11 mi jauhnya
Phase 1 Study Evaluating the Safety and PK of ADU-1805 in Advanced Solid Tumors
Menerima pesertaFase 1
- Virginia Cancer Specialists, Fairfax · 11 mi jauhnya
A Study of GV20-0251 Monotherapy and GV20-0251 in Combination With Pembrolizumab in Participants With Solid Tumor Malignancies
Menerima pesertaFase 1/2
- Virginia Cancer Specialists, Fairfax · 11 mi jauhnya
A Study of OR502, a Monoclonal Antibody Targeting LILRB2, Alone and in Combination With Anticancer Agents
Menerima pesertaFase 1/2
- NEXT Virginia, Fairfax · 11 mi jauhnya
A Study in Patients With Advanced Cancers
Menerima pesertaFase 1/2
- NEXT Oncology Virginia, Fairfax · 11 mi jauhnya
Uji klinis Kanker (semua jenis) di kota lain
- Houston, TX121 studi
- New York City, NY110 studi
- Boston, MA86 studi
- Los Angeles, CA73 studi
- Nashville, TN65 studi
- Philadelphia, PA59 studi
- Durham, NC58 studi
- Washington, DC58 studi
- Chicago, IL51 studi
- Seattle, WA49 studi
- Atlanta, GA49 studi
- St. Louis, MO46 studi
Studi lain di Arlington
- Kanker Paru Non-Sel Kecil104 studi
- Kanker Metastatik53 studi
- Kanker Kolorektal52 studi
- Kanker Payudara46 studi
- Kanker Ovarium46 studi
- Kanker Paru41 studi
- Kanker Endometrium39 studi
- Kanker Pankreas33 studi
- Karsinoma Sel Skuamosa Kepala dan Leher26 studi
- Kanker Paru Sel Kecil23 studi
- Kanker Payudara Triple-Negatif20 studi
- Kanker Lambung20 studi
Dari ClinicalTrials.gov, data diambil 5 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.